⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of 1ST Biotherapeutics, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
1ST Biotherapeutics, Inc.
↗Yongin, South Korea
1ST Biotherapeutics is a South Korean clinical-stage biopharmaceutical company founded in 2016. The company focuses on discovering and developing first-in-class small molecule therapeutics to address significant unmet medical needs in neurodegenerative diseases, immuno-oncology, and rare diseases.
1STBIO utilizes a proprietary AI-based drug discovery platform and genomic-based target discovery to enhance R&D efficiency. The company maintains a global network of collaborations with academic institutions, hospitals, CROs, and major pharmaceutical partners to advance its pipeline and clinical development programs.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Neurodegenerative diseases, Immuno-oncology
SIZE & FINANCIALS
Employees:1-50
Founded:2016
Ownership:private
Status:operating
FUNDING
Stage:Series D
Total Raised:$83.17M
Investors:Smilegate Investment, Korea Investment Partners, DSC Investment, Groom Investment, Double Capital, Anda Investment Partners, DAYLI Partners, LigaChem Biosciences, Mirae Asset Securities, CKD Venture Capital
PIPELINE
Stage:Phase 1
Lead Drug Stage:Phase 1
Modalities:Small molecule
Active Trials:1
Trial Phases:Phase 1: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:The Michael J. Fox Foundation (LITE program), LigaChem Biosciences (ADC payloads and immuno-oncology), Lilly TuneLab (Discovery network), D&D Pharmatech, MSD
COMPETITION
Position:Emerging
Competitors:Jazz Pharmaceuticals, Moderna, Sana Biotechnology
LEADERSHIP
Key Executives:
Jamie Jae Eun Kim - CEO & Founder
Scientific Founders:Jamie Jae Eun Kim
LINKS
Website:1stbio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 1ST Biotherapeutics, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.